Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access

Purpose To compare the safety and outcome of transjugular versus percutaneous technique in recanalization of non-cirrhotic, non-malignant portal vein thrombosis. Methods We present a retrospective bicentric analysis of 21 patients with non-cirrhotic, non-malignant PVT, who were treated between 2016...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Abdominal imaging 2022-03, Vol.47 (3), p.1177-1186
Hauptverfasser: Mansour, Nabeel, Öcal, Osman, Gerwing, Mirjam, Köhler, Michael, Deniz, Sinan, Heinzow, Hauke, Steib, Christian, Angele, Martin K., Seidensticker, Max, Ricke, Jens, Wildgruber, Moritz
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1186
container_issue 3
container_start_page 1177
container_title Abdominal imaging
container_volume 47
creator Mansour, Nabeel
Öcal, Osman
Gerwing, Mirjam
Köhler, Michael
Deniz, Sinan
Heinzow, Hauke
Steib, Christian
Angele, Martin K.
Seidensticker, Max
Ricke, Jens
Wildgruber, Moritz
description Purpose To compare the safety and outcome of transjugular versus percutaneous technique in recanalization of non-cirrhotic, non-malignant portal vein thrombosis. Methods We present a retrospective bicentric analysis of 21 patients with non-cirrhotic, non-malignant PVT, who were treated between 2016 and 2021 by interventional recanalization via different access routes (percutaneous [PT] vs. transjugular in transhepatic portosystemic shunt [TIPS] technique). Complication rates with a focus on periprocedural bleeding and patency as well as outcome were compared. Results Of the 21 patients treated (median age 48 years, range of 19–78), seven (33%) patients had an underlying prothrombotic condition. While 14 (57%) patients were treated for acute PVT, seven (43%) patients had progressive thrombosis with known chronic PVT. Nine patients underwent initial recanalization via PT access and twelve via TIPS technique. There was no significant difference in complete technical success rate according to initial access route (55.5% in PT group vs. 83.3% in TIPS group, p  = 0.331). However, creation of an actual TIPS was associated with higher technical success in restoring portal venous flow (86.6% vs. 33.3%, p  = 0.030). 13 (61.9%) patients received thrombolysis. Nine (42.8%) patients experienced hemorrhagic complications. In a multivariate analysis, thrombolysis ( p  = 0.049) and PT access as the first procedure ( p  = 0.045) were significant risk factors for bleeding. Conclusion Invasive recanalization of the portal vein in patients with PVT and absence of cirrhosis and malignancy offers a good therapeutic option with high recanalization and patency rates. Bleeding complications result predominantly from a percutaneous access and high amounts of thrombolytics used; therefore, recanalization via TIPS technique should be favored.
doi_str_mv 10.1007/s00261-022-03411-w
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8863683</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2619212047</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-6ba982dad10932e8dd13ca2452658c11eb3a96c04e43a27fe366bd844ebcf0a33</originalsourceid><addsrcrecordid>eNp9Ustu1TAQjRCIVqU_wAJZYsOCgF95sUCqKgqVKrEBiZ01cebe-Cqxg-3cq_JBfGedplweC1a2z5w545k5Wfac0TeM0uptoJSXLKec51RIxvLDo-yUi7LMKS3qx8e7_HaSnYewo5SysmCMF0-zE1FQnoDqNPt5bSP6PdponIWBeNSQTvMDFoDEHj1Mt8RYMiUk0QI5mNgT62yujfe9i0a_vn-OKW1rwUYyOR-T1h7NouDd2Lpgwjui3TiBNyEJtxgPiCnswYbdvJ0H8CnBhzmsWI9LQU1AawzhWfZkA0PA84fzLPt69eHL5af85vPH68uLm1zLSsa8bKGpeQcdo43gWHcdExq4LHhZ1JoxbAU0paYSpQBebTDNqO1qKbHVGwpCnGXvV91pbkfsdGrYw6Amb0bwt8qBUX9HrOnV1u1VXZeirBeBVw8C3n2fMUQ1mqBxGMCim4NKO2s441RWifryH-rOzT4Nf2EJVsmqrprE4itLexeCx83xM4yqxQlqdYJKTlD3TlCHlPTizzaOKb_2nghiJYQUslv0v2v_R_YO3knFvQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2631747879</pqid></control><display><type>article</type><title>Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access</title><source>Springer Nature - Complete Springer Journals</source><creator>Mansour, Nabeel ; Öcal, Osman ; Gerwing, Mirjam ; Köhler, Michael ; Deniz, Sinan ; Heinzow, Hauke ; Steib, Christian ; Angele, Martin K. ; Seidensticker, Max ; Ricke, Jens ; Wildgruber, Moritz</creator><creatorcontrib>Mansour, Nabeel ; Öcal, Osman ; Gerwing, Mirjam ; Köhler, Michael ; Deniz, Sinan ; Heinzow, Hauke ; Steib, Christian ; Angele, Martin K. ; Seidensticker, Max ; Ricke, Jens ; Wildgruber, Moritz</creatorcontrib><description>Purpose To compare the safety and outcome of transjugular versus percutaneous technique in recanalization of non-cirrhotic, non-malignant portal vein thrombosis. Methods We present a retrospective bicentric analysis of 21 patients with non-cirrhotic, non-malignant PVT, who were treated between 2016 and 2021 by interventional recanalization via different access routes (percutaneous [PT] vs. transjugular in transhepatic portosystemic shunt [TIPS] technique). Complication rates with a focus on periprocedural bleeding and patency as well as outcome were compared. Results Of the 21 patients treated (median age 48 years, range of 19–78), seven (33%) patients had an underlying prothrombotic condition. While 14 (57%) patients were treated for acute PVT, seven (43%) patients had progressive thrombosis with known chronic PVT. Nine patients underwent initial recanalization via PT access and twelve via TIPS technique. There was no significant difference in complete technical success rate according to initial access route (55.5% in PT group vs. 83.3% in TIPS group, p  = 0.331). However, creation of an actual TIPS was associated with higher technical success in restoring portal venous flow (86.6% vs. 33.3%, p  = 0.030). 13 (61.9%) patients received thrombolysis. Nine (42.8%) patients experienced hemorrhagic complications. In a multivariate analysis, thrombolysis ( p  = 0.049) and PT access as the first procedure ( p  = 0.045) were significant risk factors for bleeding. Conclusion Invasive recanalization of the portal vein in patients with PVT and absence of cirrhosis and malignancy offers a good therapeutic option with high recanalization and patency rates. Bleeding complications result predominantly from a percutaneous access and high amounts of thrombolytics used; therefore, recanalization via TIPS technique should be favored.</description><identifier>ISSN: 2366-004X</identifier><identifier>EISSN: 2366-0058</identifier><identifier>DOI: 10.1007/s00261-022-03411-w</identifier><identifier>PMID: 35020007</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Access routes ; Bleeding ; Cirrhosis ; Complications ; Gastroenterology ; Hemorrhage ; Hepatology ; Imaging ; Interventional Radiology ; Liver cirrhosis ; Malignancy ; Medicine ; Medicine &amp; Public Health ; Multivariate analysis ; Portal vein ; Radiology ; Risk analysis ; Risk factors ; Thromboembolism ; Thrombolysis ; Thrombosis ; Veins &amp; arteries</subject><ispartof>Abdominal imaging, 2022-03, Vol.47 (3), p.1177-1186</ispartof><rights>The Author(s) 2022</rights><rights>2022. The Author(s).</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-6ba982dad10932e8dd13ca2452658c11eb3a96c04e43a27fe366bd844ebcf0a33</citedby><cites>FETCH-LOGICAL-c474t-6ba982dad10932e8dd13ca2452658c11eb3a96c04e43a27fe366bd844ebcf0a33</cites><orcidid>0000-0002-7228-6963</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00261-022-03411-w$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00261-022-03411-w$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35020007$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mansour, Nabeel</creatorcontrib><creatorcontrib>Öcal, Osman</creatorcontrib><creatorcontrib>Gerwing, Mirjam</creatorcontrib><creatorcontrib>Köhler, Michael</creatorcontrib><creatorcontrib>Deniz, Sinan</creatorcontrib><creatorcontrib>Heinzow, Hauke</creatorcontrib><creatorcontrib>Steib, Christian</creatorcontrib><creatorcontrib>Angele, Martin K.</creatorcontrib><creatorcontrib>Seidensticker, Max</creatorcontrib><creatorcontrib>Ricke, Jens</creatorcontrib><creatorcontrib>Wildgruber, Moritz</creatorcontrib><title>Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access</title><title>Abdominal imaging</title><addtitle>Abdom Radiol</addtitle><addtitle>Abdom Radiol (NY)</addtitle><description>Purpose To compare the safety and outcome of transjugular versus percutaneous technique in recanalization of non-cirrhotic, non-malignant portal vein thrombosis. Methods We present a retrospective bicentric analysis of 21 patients with non-cirrhotic, non-malignant PVT, who were treated between 2016 and 2021 by interventional recanalization via different access routes (percutaneous [PT] vs. transjugular in transhepatic portosystemic shunt [TIPS] technique). Complication rates with a focus on periprocedural bleeding and patency as well as outcome were compared. Results Of the 21 patients treated (median age 48 years, range of 19–78), seven (33%) patients had an underlying prothrombotic condition. While 14 (57%) patients were treated for acute PVT, seven (43%) patients had progressive thrombosis with known chronic PVT. Nine patients underwent initial recanalization via PT access and twelve via TIPS technique. There was no significant difference in complete technical success rate according to initial access route (55.5% in PT group vs. 83.3% in TIPS group, p  = 0.331). However, creation of an actual TIPS was associated with higher technical success in restoring portal venous flow (86.6% vs. 33.3%, p  = 0.030). 13 (61.9%) patients received thrombolysis. Nine (42.8%) patients experienced hemorrhagic complications. In a multivariate analysis, thrombolysis ( p  = 0.049) and PT access as the first procedure ( p  = 0.045) were significant risk factors for bleeding. Conclusion Invasive recanalization of the portal vein in patients with PVT and absence of cirrhosis and malignancy offers a good therapeutic option with high recanalization and patency rates. Bleeding complications result predominantly from a percutaneous access and high amounts of thrombolytics used; therefore, recanalization via TIPS technique should be favored.</description><subject>Access routes</subject><subject>Bleeding</subject><subject>Cirrhosis</subject><subject>Complications</subject><subject>Gastroenterology</subject><subject>Hemorrhage</subject><subject>Hepatology</subject><subject>Imaging</subject><subject>Interventional Radiology</subject><subject>Liver cirrhosis</subject><subject>Malignancy</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Multivariate analysis</subject><subject>Portal vein</subject><subject>Radiology</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Thromboembolism</subject><subject>Thrombolysis</subject><subject>Thrombosis</subject><subject>Veins &amp; arteries</subject><issn>2366-004X</issn><issn>2366-0058</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9Ustu1TAQjRCIVqU_wAJZYsOCgF95sUCqKgqVKrEBiZ01cebe-Cqxg-3cq_JBfGedplweC1a2z5w545k5Wfac0TeM0uptoJSXLKec51RIxvLDo-yUi7LMKS3qx8e7_HaSnYewo5SysmCMF0-zE1FQnoDqNPt5bSP6PdponIWBeNSQTvMDFoDEHj1Mt8RYMiUk0QI5mNgT62yujfe9i0a_vn-OKW1rwUYyOR-T1h7NouDd2Lpgwjui3TiBNyEJtxgPiCnswYbdvJ0H8CnBhzmsWI9LQU1AawzhWfZkA0PA84fzLPt69eHL5af85vPH68uLm1zLSsa8bKGpeQcdo43gWHcdExq4LHhZ1JoxbAU0paYSpQBebTDNqO1qKbHVGwpCnGXvV91pbkfsdGrYw6Amb0bwt8qBUX9HrOnV1u1VXZeirBeBVw8C3n2fMUQ1mqBxGMCim4NKO2s441RWifryH-rOzT4Nf2EJVsmqrprE4itLexeCx83xM4yqxQlqdYJKTlD3TlCHlPTizzaOKb_2nghiJYQUslv0v2v_R_YO3knFvQ</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Mansour, Nabeel</creator><creator>Öcal, Osman</creator><creator>Gerwing, Mirjam</creator><creator>Köhler, Michael</creator><creator>Deniz, Sinan</creator><creator>Heinzow, Hauke</creator><creator>Steib, Christian</creator><creator>Angele, Martin K.</creator><creator>Seidensticker, Max</creator><creator>Ricke, Jens</creator><creator>Wildgruber, Moritz</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>JQ2</scope><scope>K7-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7228-6963</orcidid></search><sort><creationdate>20220301</creationdate><title>Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access</title><author>Mansour, Nabeel ; Öcal, Osman ; Gerwing, Mirjam ; Köhler, Michael ; Deniz, Sinan ; Heinzow, Hauke ; Steib, Christian ; Angele, Martin K. ; Seidensticker, Max ; Ricke, Jens ; Wildgruber, Moritz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-6ba982dad10932e8dd13ca2452658c11eb3a96c04e43a27fe366bd844ebcf0a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Access routes</topic><topic>Bleeding</topic><topic>Cirrhosis</topic><topic>Complications</topic><topic>Gastroenterology</topic><topic>Hemorrhage</topic><topic>Hepatology</topic><topic>Imaging</topic><topic>Interventional Radiology</topic><topic>Liver cirrhosis</topic><topic>Malignancy</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Multivariate analysis</topic><topic>Portal vein</topic><topic>Radiology</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Thromboembolism</topic><topic>Thrombolysis</topic><topic>Thrombosis</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mansour, Nabeel</creatorcontrib><creatorcontrib>Öcal, Osman</creatorcontrib><creatorcontrib>Gerwing, Mirjam</creatorcontrib><creatorcontrib>Köhler, Michael</creatorcontrib><creatorcontrib>Deniz, Sinan</creatorcontrib><creatorcontrib>Heinzow, Hauke</creatorcontrib><creatorcontrib>Steib, Christian</creatorcontrib><creatorcontrib>Angele, Martin K.</creatorcontrib><creatorcontrib>Seidensticker, Max</creatorcontrib><creatorcontrib>Ricke, Jens</creatorcontrib><creatorcontrib>Wildgruber, Moritz</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Computer Science Collection</collection><collection>Computer Science Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Abdominal imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mansour, Nabeel</au><au>Öcal, Osman</au><au>Gerwing, Mirjam</au><au>Köhler, Michael</au><au>Deniz, Sinan</au><au>Heinzow, Hauke</au><au>Steib, Christian</au><au>Angele, Martin K.</au><au>Seidensticker, Max</au><au>Ricke, Jens</au><au>Wildgruber, Moritz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access</atitle><jtitle>Abdominal imaging</jtitle><stitle>Abdom Radiol</stitle><addtitle>Abdom Radiol (NY)</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>47</volume><issue>3</issue><spage>1177</spage><epage>1186</epage><pages>1177-1186</pages><issn>2366-004X</issn><eissn>2366-0058</eissn><abstract>Purpose To compare the safety and outcome of transjugular versus percutaneous technique in recanalization of non-cirrhotic, non-malignant portal vein thrombosis. Methods We present a retrospective bicentric analysis of 21 patients with non-cirrhotic, non-malignant PVT, who were treated between 2016 and 2021 by interventional recanalization via different access routes (percutaneous [PT] vs. transjugular in transhepatic portosystemic shunt [TIPS] technique). Complication rates with a focus on periprocedural bleeding and patency as well as outcome were compared. Results Of the 21 patients treated (median age 48 years, range of 19–78), seven (33%) patients had an underlying prothrombotic condition. While 14 (57%) patients were treated for acute PVT, seven (43%) patients had progressive thrombosis with known chronic PVT. Nine patients underwent initial recanalization via PT access and twelve via TIPS technique. There was no significant difference in complete technical success rate according to initial access route (55.5% in PT group vs. 83.3% in TIPS group, p  = 0.331). However, creation of an actual TIPS was associated with higher technical success in restoring portal venous flow (86.6% vs. 33.3%, p  = 0.030). 13 (61.9%) patients received thrombolysis. Nine (42.8%) patients experienced hemorrhagic complications. In a multivariate analysis, thrombolysis ( p  = 0.049) and PT access as the first procedure ( p  = 0.045) were significant risk factors for bleeding. Conclusion Invasive recanalization of the portal vein in patients with PVT and absence of cirrhosis and malignancy offers a good therapeutic option with high recanalization and patency rates. Bleeding complications result predominantly from a percutaneous access and high amounts of thrombolytics used; therefore, recanalization via TIPS technique should be favored.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>35020007</pmid><doi>10.1007/s00261-022-03411-w</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-7228-6963</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2366-004X
ispartof Abdominal imaging, 2022-03, Vol.47 (3), p.1177-1186
issn 2366-004X
2366-0058
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8863683
source Springer Nature - Complete Springer Journals
subjects Access routes
Bleeding
Cirrhosis
Complications
Gastroenterology
Hemorrhage
Hepatology
Imaging
Interventional Radiology
Liver cirrhosis
Malignancy
Medicine
Medicine & Public Health
Multivariate analysis
Portal vein
Radiology
Risk analysis
Risk factors
Thromboembolism
Thrombolysis
Thrombosis
Veins & arteries
title Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T05%3A13%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interventional%20recanalization%20therapy%20in%20patients%20with%20non-cirrhotic,%20non-malignant%20portal%20vein%20thrombosis:%20comparison%20between%20transjugular%20versus%20transhepatic%20access&rft.jtitle=Abdominal%20imaging&rft.au=Mansour,%20Nabeel&rft.date=2022-03-01&rft.volume=47&rft.issue=3&rft.spage=1177&rft.epage=1186&rft.pages=1177-1186&rft.issn=2366-004X&rft.eissn=2366-0058&rft_id=info:doi/10.1007/s00261-022-03411-w&rft_dat=%3Cproquest_pubme%3E2619212047%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2631747879&rft_id=info:pmid/35020007&rfr_iscdi=true